These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 9420218)

  • 1. Infectious cellular load in human immunodeficiency virus type 1 (HIV-1)-infected individuals and susceptibility of peripheral blood mononuclear cells from their exposed partners to non-syncytium-inducing HIV-1 as major determinants for HIV-1 transmission in homosexual couples.
    Blaak H; van't Wout AB; Brouwer M; Cornelissen M; Kootstra NA; Albrecht-van Lent N; Keet RP; Goudsmit J; Coutinho RA; Schuitemaker H
    J Virol; 1998 Jan; 72(1):218-24. PubMed ID: 9420218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MT-2 tropism and CCR-5 genotype strongly influence disease progression in HIV-1-infected individuals.
    Bratt G; Leandersson AC; Albert J; Sandström E; Wahren B
    AIDS; 1998 May; 12(7):729-36. PubMed ID: 9619804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
    Paxton WA; Kang S; Koup RA
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S89-92. PubMed ID: 9581891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between CCR5 genotype and the clinical course of HIV-1 infection.
    de Roda Husman AM; Koot M; Cornelissen M; Keet IP; Brouwer M; Broersen SM; Bakker M; Roos MT; Prins M; de Wolf F; Coutinho RA; Miedema F; Goudsmit J; Schuitemaker H
    Ann Intern Med; 1997 Nov; 127(10):882-90. PubMed ID: 9382366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex.
    van Rij RP; Portegies P; Hallaby T; Lange JM; Visser J; de Roda Husman AM; van 't Wout AB; Schuitemaker H
    J Infect Dis; 1999 Sep; 180(3):854-7. PubMed ID: 10438379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of CCR5 Delta32/+ deletion on herpes zoster among HIV-1-infected homosexual men.
    Krol A; Lensen R; Veenstra J; Prins M; Schuitemaker H; Coutinho RA
    Eur J Epidemiol; 2006; 21(6):469-73. PubMed ID: 16703416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined effect of CCR5-Delta32 heterozygosity and the CCR5 promoter polymorphism -2459 A/G on CCR5 expression and resistance to human immunodeficiency virus type 1 transmission.
    Hladik F; Liu H; Speelmon E; Livingston-Rosanoff D; Wilson S; Sakchalathorn P; Hwangbo Y; Greene B; Zhu T; McElrath MJ
    J Virol; 2005 Sep; 79(18):11677-84. PubMed ID: 16140745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 infection in individuals with the CCR5-Delta32/Delta32 genotype: acquisition of syncytium-inducing virus at seroconversion.
    Sheppard HW; Celum C; Michael NL; O'Brien S; Dean M; Carrington M; Dondero D; Buchbinder SP
    J Acquir Immune Defic Syndr; 2002 Mar; 29(3):307-13. PubMed ID: 11873082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy.
    van't Wout AB; Ran LJ; Kuiken CL; Kootstra NA; Pals ST; Schuitemaker H
    J Virol; 1998 Jan; 72(1):488-96. PubMed ID: 9420250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of HIV isolates from Puerto Rican maternal-infant pairs reveal predominance of non-syncytium inducing (NSI) variants with CCR5 genotype.
    Melendez-Guerrero LM; Arroyo MA; Vega ME; Jimenez E; Hillyer GV; Cadilla CL
    Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL39-47. PubMed ID: 11936872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of CCR5-Δ32 mutation among individuals with high risk behaviors, neonates born to HIV-1 infected mothers, HIV-1 infected individuals, and healthy people in an Iranian population.
    Donyavi T; Bokharaei-Salim F; Nahand JS; Garshasbi S; Esghaei M; Sadeghi M; Jamshidi S; Khanaliha K
    J Med Virol; 2020 Aug; 92(8):1158-1164. PubMed ID: 31854469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner.
    Frange P; Meyer L; Jung M; Goujard C; Zucman D; Abel S; Hochedez P; Gousset M; Gascuel O; Rouzioux C; Chaix ML;
    PLoS One; 2013; 8(7):e69144. PubMed ID: 23874894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy.
    Lathey JL; Tierney C; Chang SY; D'Aquila RT; Bettendorf DM; Alexander HC; Santini CD; Hughes AM; Barroga CF; Spector SA; Landes JE; Hammer SM; Katzenstein DA
    J Infect Dis; 2001 Dec; 184(11):1402-11. PubMed ID: 11709782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased susceptibility of peripheral blood mononuclear cells from individuals heterozygous for a mutant CCR5 allele to HIV infection.
    Kim A; Pettoello-Mantovani M; Goldstein H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Oct; 19(2):145-9. PubMed ID: 9768623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 subtype C syncytium- and non-syncytium-inducing phenotypes and coreceptor usage among Ethiopian patients with AIDS.
    Abebe A; Demissie D; Goudsmit J; Brouwer M; Kuiken CL; Pollakis G; Schuitemaker H; Fontanet AL; Rinke de Wit TF
    AIDS; 1999 Jul; 13(11):1305-11. PubMed ID: 10449282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential contributions of viral envelope and host genetic factors in a human immunodeficiency virus type 1-infected long-term survivor.
    Grovit-Ferbas K; Ferbas J; Gudeman V; Sadeghi S; Goetz MB; Giorgi JV; Chen IS; O'Brien WA
    J Virol; 1998 Nov; 72(11):8650-8. PubMed ID: 9765405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural controlled HIV infection: preserved HIV-specific immunity despite undetectable replication competent virus.
    Kloosterboer N; Groeneveld PH; Jansen CA; van der Vorst TJ; Koning F; Winkel CN; Duits AJ; Miedema F; van Baarle D; van Rij RP; Brinkman K; Schuitemaker H
    Virology; 2005 Aug; 339(1):70-80. PubMed ID: 15987650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCR5 genotype and HIV-1 infection in perinatally-exposed infants.
    Mas A; Español T; Heredia A; Pedraza MA; Hernandez M; Caragol I; Fernando M; Bertran JM; Alcami J; Soriano V
    J Infect; 1999 Jan; 38(1):9-11. PubMed ID: 10090498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cord blood mononuclear cells are preferentially infected by non-syncytium-inducing, macrophage-tropic human immunodeficiency virus type 1 isolates.
    Reinhardt PP; Reinhardt B; Lathey JL; Spector SA
    J Clin Microbiol; 1995 Feb; 33(2):292-7. PubMed ID: 7714181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status.
    Hoffman TL; MacGregor RR; Burger H; Mick R; Doms RW; Collman RG
    J Infect Dis; 1997 Oct; 176(4):1093-6. PubMed ID: 9333175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.